SEO URLwww.firestrike.ai/deals/lifeward-oramed-pharmaceuticals-acquisition-2026
acquisitionAnnounced · Jan 13, 2026medical devicesSource · CredibleArticle · Factual
Oramed Pharmaceuticals acquires Lifeward
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$47M
Target
Lifeward
Acquirer
Oramed Pharmaceuticals
Financial Stake
Status
Pending
Oramed Pharmaceuticals agreed to acquire Lifeward. Reported deal value: $47M. Status: Pending. Sector: medical devices. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-13. Figures and status may change as filings and press coverage update.
Lifeward will sell nearly half of the company to Oramed Pharmaceuticals in exchange for the firm protein delivery technology
Deal timeline
Announced
Jan 13, 2026 · wbjournal.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in medical devices with a reported deal value of $47M. Figures and status may change as sources update.
Sources: wbjournal.com · Primary article · FireStrike proprietary index